Digital Health

There are a number of obstacles confronting today’s clinical trial research field:• Failure to accrue sufficient participants. Protocols designed without the benefit of real...

Introduction - the problem:Treatment of oncological patients with targeted therapy has been carried out in our country for over 15 years. However, compared to...

Grupy tematyczne Klastra (ang. SIG - Special Interest Groups) mogą wnosić w działalność Partnerów Klastra nową jakość, ale muszą spełniać pewne warunki, które pozwolą...

The new challenge is the usage of in silico methods in the field of nanotechnology. Nanotechnology is an innovative science that involves the designing, characterization, production...